MARKET

CRMD

CRMD

Cormedix
NASDAQ
11.66
-0.37
-3.08%
After Hours: 11.73 +0.07 +0.60% 19:43 05/09 EDT
OPEN
12.11
PREV CLOSE
12.03
HIGH
12.31
LOW
11.42
VOLUME
4.58M
TURNOVER
--
52 WEEK HIGH
13.85
52 WEEK LOW
3.610
MARKET CAP
790.84M
P/E (TTM)
51.75
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 2d ago
CorMedix’s Strong Q1 Performance and Growth Prospects Justify Buy Rating
TipRanks · 3d ago
Cormedix (CRMD) Receives a Buy from RBC Capital
TipRanks · 4d ago
CorMedix Price Target Raised to $15.00/Share From $12.00 by Needham
Dow Jones · 4d ago
CorMedix Is Maintained at Buy by Needham
Dow Jones · 4d ago
CORMEDIX INC <CRMD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $20 FROM $17
Reuters · 4d ago
Needham Maintains Buy on Cormedix, Raises Price Target to $15
Benzinga · 4d ago
CorMedix Inc. Reports Strong Q1 2025 Results
TipRanks · 5d ago
More
About CRMD
More
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Recently
Symbol
Price
%Change

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.